Dr. Husserl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4712 Richland Ave
Metairie, LA 70002Phone+1 504-455-5339
Education & Training
- Ochsner Clinic FoundationFellowship, Nephrology, 1977 - 1978
- Ochsner Clinic FoundationResidency, Internal Medicine, 1976 - 1977
- Louisiana State University School of MedicineResidency, Internal Medicine, 1972 - 1975
- Universidad del Valle Health SciencesClass of 1970
- Universidad de Los AndesNo degree, Pre-medicine, 1965
Certifications & Licensure
- LA State Medical License 1977 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 36 citationsElevated plasma levels of endostatin are associated with chronic kidney diseaseJing Chen, L. Lee Hamm, Myra A. Kleinpeter, Fred Husserl, Islam Enver Khan
American Journal of Nephrology. 2012-03-27 - 56 citationsThe Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialPatrick S. Parfrey, Tilman B. Drüeke, Geoffrey A. Block, Ricardo Correa-Rotter, Jürgen Floege
Clinical Journal of the American Society of Nephrology. 2015-05-07 - 297 citationsCinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Mult...Jill S. Lindberg, Bruce F. Culleton, Gordon Wong, Michael F. Borah, Roderick V. Clark
Journal of the American Society of Nephrology. 2005-03-01
Journal Articles
- A trial of darbepoetin alfa in type 2 diabetes and chronic kidney diseasePfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckhardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Re..., N Engl J Med, 1/19/2009
- Simulatneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCISprague SM, Evenepoel P, Curzi MP, Gonzalez MT, Husserl FE, Kopyt N, Sterling LR, Mix C, Wong G, Clin J Am Soc Nephrol, 1/1/2009
- A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patents with comparable lipid control: th...Qunibi W, Moustafa M, Muenz LR, He Dy, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators, Am J Kidney Dis, 1/1/2008
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Arterial Stiffness is Associated withVascular calcification In Chronic Kidney DiseaseChen J, Townsend RR, Budoff MJ, Ahmed FA, Chen CS, Liu Y, Mills KT, Khan E, Laguardia HA, Kumbala DR, Kleinpeter MA, Husserl F, Simon EE, Hamm LL, He J, ASN, 1/1/2012
- Abnormail Nitric Oxide Metabolism, Prothrombotic state, Impaired Angiogenesis and risk of CKDChen J, Hamm LL, Kleinpeter M, Husserl F, Khan E, Teran FJ, Browne G, Chen CS, Liu Y, Mills KT, Lustigova E, Xu R, Rogers S, Tarsia J, Shah K, He C, Alper AB, He J, ASN, 1/1/2011
- Association of Impaired Endotherlium-Dependant and Nitroglycerin-Induced Vasodilatation with Risk of Chronic Kidney Disease (CKD)Chen J, Hamm LL, Husserl F, Mohler ER, Arora R, Khan E, Alper B, Kleinpeter M, Sheneva R, Simon E, He J, ASN, 1/1/2010
- Join now to see all
Lectures
- Evaluating Renal Function in the Primary Care SettingNew Orleans, LA - 1/1/2011
- Working with Non-adherent Patients: Challenges and SolutionsLignano Sabbiadoro, Udine, Italy - 1/14/2008
- Ethical Dilemmas of Designing and Conducting Clinical TrialsLignano Sabbiadoro, Udine, Italy - 1/14/2008
- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: